
Zimmer Biomet company profile
$103.21−1.29%Close 13 Nov 2026
About Zimmer Biomet
Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products, including knee and hip implants; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; bone cement; surgical products; and integrated digital and robotic technologies. Its customers include orthopedic surgeons, neurosurgeons, healthcare institutions, stocking distributors, healthcare dealers and healthcare purchasing organizations. Products are sold directly to hospitals and ambulatory surgery centers and through distributors and dealers. The company operates through three regional segments: the Americas, Europe, Middle East and Africa, and Asia Pacific, with the U.S. and Japan as the largest markets within the Americas and Asia Pacific segments, respectively.
A summary of the business section of the company's latest annual report, filed 20 Feb 2026.
Company facts
| Ticker | ZBH · NYSE |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Equipment |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1136869 |
|---|
| Latest annual report | 10-K, filed 20 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Ivan Tornos | Chairman, President and CEO · Director | 304K · < 1% | Shares withheld for tax, 6 Mar 2026 |
|---|
| Suketu Upadhyay | Exec VP, CFO | 260K · < 1% | Shares withheld for tax, 6 Mar 2026 |
|---|
| Wilfred van Zuilen | Group Pres, EMEA | 90.6K · < 1% | Option exercise, 6 Mar 2026 |
|---|
| Jehanzeb Noor | See remarks below. | 202 · < 1% | Option exercise, 1 Apr 2026 |
|---|
| Campbell Gary Craig | President, Americas | — | Option exercise, 1 Oct 2026 |
|---|
| Kevin Thornal | Grp Pres-Global Business | — | Open-market sale, 11 Sep 2026 |
|---|
| Phipps Chad F | See remarks below. | — | Open-market sale, 4 Sep 2026 |
|---|
| Yi Sang | Group President, Asia Pacific | — | Open-market sale, 29 May 2026 |
|---|
| Winkler Lori | SVP and CHRO | — | Open-market sale, 12 Mar 2026 |
|---|
| Stellato Paul A | VP, Controller, CAO | — | Option exercise, 6 Mar 2026 |
|---|
| Bezjak Mark | President, Americas | — | Shares withheld for tax, 6 Mar 2025 |
|---|
| Ellingson Rachel | Chief Administrative Officer | — | Option exercise, 20 Feb 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
ZBH in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.